/startuppedia/media/media_files/U5fhPnL4V57cdjgT5amj.png)
Mr. Nikhil Nanda, Managing Director of JHS Svendgaard Laboratories
This capital injection, led by the promoters of the Dabur Group, alongside contributions from Nikhil Nanda, Managing Director of JHS Svendgaard Laboratories, and Coeus Global Opportunities Fund, will facilitate the company's strategic expansion plans.
Prominent Investors Back JHS’s Strategic Vision
Notably, M/s Puran Associates, M/s Milky Investment, M/s M. B. Finmart, and M/s VIC Enterprises are owned by Dr. Anand Chand Burman, Mrs. Minnie Burman, and Mr. Mohit Burman, prominent promoters of the Dabur Group, have demonstrated their confidence in JHS’s strategic vision by contributing to this investment.
Greenfield Project in Jammu and Kashmir
The funds will be utilized for setting up a greenfield project in Jammu and Kashmir under the J&K Industrial Policy, which offers fiscal benefits for up to 10 years. The project, estimated at ₹120 Crore, will expand JHS’s product categories to include Oral Care, Soap, and Juices/Aerated Beverages, aiming to generate additional business of ₹500 Crore.
Expansion into Horeca, Institutional, and Export Markets
JHS is also focusing on expanding into Horeca, institutional, and export markets through white labeling and market penetration.
Commenting on the announcement, Mr. Nikhil Nanda, Managing Director of JHS Svendgaard Laboratories, said, “This investment marks a significant milestone for our company. The confidence shown by key investors underscores our strategic vision and potential. The funds raised will enable us to expand our product portfolio and enhance our market presence, driving significant profitability and growth in the coming years.”
Strong Order Book and Financing Plan
JHS holds a strong order book for FY 2024-25, including orders from market leaders such as Dabur, HUL, and Patanjali. The greenfield project in Jammu will be financed through 50% equity and internal accruals, with the remainder covered by debt. Construction begins in September 2024, targeting a completion date within 15-18 months and operational start by January 2026.
Company Background and Future Plans
Established in 2004 and listed on the BSE and NSE, JHS, a leading player in the oral hygiene product manufacturing sector, operates a state-of-the-art oral care manufacturing campus across 20 acres in Kala-Amb, Himachal Pradesh. The facility is ISO 9001, GMP, FDA, and SMETA certified. With expansions at its Himachal Pradesh facility and new initiatives in Jammu, JHS aims to enhance EBITDA margins to double digits, leveraging fiscal advantages to go upto 20% profitability in J&K.